Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 12,749 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 12,749 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $348,175.19. Following the completion of the transaction, the chief operating officer now directly owns 755,459 shares of the company’s stock, valued at approximately $20,631,585.29. The trade was a 1.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Stock Performance

PHR opened at $27.89 on Friday. The stock has a 50-day moving average of $24.00 and a 200-day moving average of $23.00. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.16. The company has a market cap of $1.62 billion, a PE ratio of -18.98 and a beta of 0.94.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same period in the previous year, the business posted ($0.58) EPS. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. As a group, equities research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Trading of Phreesia

Hedge funds have recently modified their holdings of the company. R Squared Ltd bought a new position in shares of Phreesia during the 4th quarter worth about $30,000. Wesbanco Bank Inc. raised its stake in shares of Phreesia by 76.9% in the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock worth $1,157,000 after acquiring an additional 20,000 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after purchasing an additional 42,973 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after purchasing an additional 55,934 shares during the last quarter. Finally, M&T Bank Corp increased its holdings in shares of Phreesia by 4.6% in the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock valued at $801,000 after purchasing an additional 1,535 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on PHR shares. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Truist Financial increased their target price on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.